Clinical characteristics and immunogenetics of BCGosis/BCGitis in Chinese children: a 6 year follow-up study - Wikidata - awgldk - TriplyDB

Clinical characteristics and immunogenetics of BCGosis/BCGitis in Chinese children: a 6 year follow-up study

Clinical characteristics and immunogenetics of BCGosis/BCGitis in Chinese children: a 6 year follow-up study

http://www.wikidata.org/entity/Q35145571

about

Clinical Features and Genetic Analysis of 48 Patients with Chronic Granulomatous Disease in a Single Center Study from Shanghai, China (2005-2015): New Studies and a Literature Review.Fulminant BCG Disease in a 7 Month Old Healthy Male Infant.BCG vaccine for immunotherapy in warts: is it really safe in a tuberculosis endemic area?BCGitis and BCGosis in children with primary immunodeficiency - imaging characteristics.

P2860

Q30235499-AE72B678-AF23-429E-89A2-A0911BBAF57D Q40136981-37AD56CA-E950-4031-8EE5-A362428745C4 Q40952077-AE1E5355-060F-4926-87F3-B11E51878B23 Q40958414-29EA8941-2601-4DD7-8347-8729FC2ACE2A

P2860

Clinical characteristics and immunogenetics of BCGosis/BCGitis in Chinese children: a 6 year follow-up study

http://www.wikidata.org/entity/Q35145571

description

2014 nî lūn-bûn

@nan

2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Clinical characteristics and i ...... dren: a 6 year follow-up study

@ast

Clinical characteristics and i ...... dren: a 6 year follow-up study

@en

type

label

Clinical characteristics and i ...... dren: a 6 year follow-up study

@ast

Clinical characteristics and i ...... dren: a 6 year follow-up study

@en

prefLabel

Clinical characteristics and i ...... dren: a 6 year follow-up study

@ast

Clinical characteristics and i ...... dren: a 6 year follow-up study

@en

P1433

Q35145571-A8828A92-08F7-4265-A92B-D51BF9D9565C

P1476

Q35145571-C750CD8D-EE8C-410D-B3D4-4CA03F4968F2

P2093

Q35145571-1268D302-B9BF-4A22-B126-E0FBC887CF14

Q35145571-2019C45C-BD3C-418B-A8A5-0B07F5A1BD7C

Q35145571-40AD8F62-A2AF-454C-84BD-20AB3917C184

Q35145571-98A552D3-88B1-435A-8487-44E1BF785CFE

Q35145571-C83CB6C4-8A86-4DDC-B169-0966D0D74388

Q35145571-CCE63C48-5EBE-4037-B42A-CF71011B4432

Q35145571-EBBD0AC9-65DD-4CED-A81F-88FF93F0FB32

P2860

Q35145571-035F0160-0565-4672-8383-5D41E5E9E1AC

Q35145571-075B1FD3-AC42-4F3F-8F34-B14553CD7CA7

Q35145571-294CE848-C5BD-4D0B-83D3-0B3C035E1492

Q35145571-44010420-91C0-4218-AF14-78F2A215FDA2

Q35145571-4F1156E0-E98D-4E37-83C4-51727C3190C0

Q35145571-641CD9D0-C67D-4D6B-B5BC-06CBFC4C4867

Q35145571-7A5A2DE7-0CC9-47B9-987A-C8E5737C3F87

Q35145571-7AAF92D3-6045-4A0A-A30F-BAC76BBFB28F

Q35145571-7EC7F6B9-4196-49D6-A162-B15F77C7FBD6

Q35145571-85C3C481-9F03-43EF-9383-E583F93937F1

P304

Q35145571-D26FAFE1-BBCC-4E4D-B96A-2C794FAB8210

P31

Q35145571-AB241F73-7CFD-4D18-A7FF-8D8FFDF3EA60

P356

Q35145571-BE8BA26B-E25D-4917-BE89-6FCA5EAB6311

P407

Q35145571-2BFD6752-F212-43BE-8287-3FE621DFBAFC

P433

Q35145571-DEB75E0F-7F16-437D-8CB5-8CB8CF971DD1

P478

Q35145571-CB42A7C1-94EE-4896-993E-75A9D45E920C

P577

Q35145571-D9D1F038-0AF2-4F4F-8446-2B6904AF5EF1

P5875

Q35145571-241F8AF9-C203-4768-918D-E4ACFACE1AAC

P698

Q35145571-0318AEF4-A2B2-47EC-B1A8-84F02E4EAD8E

P932

Q35145571-856A8A73-673E-41D3-B776-F4A677BF8FE9

P356

JOURNAL.PONE.0094485

P1433

P1476

Clinical characteristics and i ...... dren: a 6 year follow-up study

@en

P2093

Danru Liu

http://www.w3.org/2001/XMLSchema#string

Jingyi Wang

http://www.w3.org/2001/XMLSchema#string

Jinqiao Sun

http://www.w3.org/2001/XMLSchema#string

Wenjing Ying

http://www.w3.org/2001/XMLSchema#string

Xiaochuan Wang

http://www.w3.org/2001/XMLSchema#string

Xiaoying Hui

http://www.w3.org/2001/XMLSchema#string

Yeheng Yu

http://www.w3.org/2001/XMLSchema#string

P2860

Chronic granulomatous disease: the European experience

Bacillus Calmette-Guérin (BCG) complications associated with primary immunodeficiency diseases

Prevalence of tuberculosis drug resistance in 10 provinces of China.

Gamma interferon treatment of patients with chronic granulomatous disease is associated with augmented production of nitric oxide by polymorphonuclear neutrophils.

Partial recessive IFN-γR1 deficiency: genetic, immunological and clinical features of 14 patients from 11 kindreds.

Revisiting human IL-12Rβ1 deficiency: a survey of 141 patients from 30 countries.

Bacille Calmette-Guérin vaccine-induced disease in HIV-infected and HIV-uninfected children.

PCR identification of Mycobacterium bovis BCG

A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity.

Identification of deletion carriers in X-linked chronic granulomatous disease by real-time PCR.

P304

e94485

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0094485

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261603789

http://www.w3.org/2001/XMLSchema#string

P698

24722620

http://www.w3.org/2001/XMLSchema#string

P932

3983162

http://www.w3.org/2001/XMLSchema#string